Impacts of the regulatory environment for gene editing on delivering beneficial products

被引:24
|
作者
Jenkins, Daniel [1 ]
Dobert, Raymond [2 ]
Atanassova, Ana [3 ]
Pavely, Chloe [4 ]
机构
[1] Pairwise Plants Serv Inc, 807 East Main St,Suite 4-100, Durham, NC 27701 USA
[2] Bayer Crop Sci, 700 Chesterfield Pkwy West, St Louis, MO 63017 USA
[3] Innovat Ctr Gent, BASF Business Coordinat Ctr, Technol Pk 101, B-9052 Ghent, Belgium
[4] Calyxt Inc, 2800 Mt Ridge Rd, Roseville, MN 55113 USA
关键词
Genome editing; Policy; Regulation; Plant breeding; Societal benefits; MUTAGENESIS; EXPRESSION; PLANTS; GRAS; OIL;
D O I
10.1007/s11627-021-10201-4
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Various genome-editing technologies have been embraced by plant breeders across the world as promising tools for the improvement of different crops to deliver consumer benefits, improve agronomic performance, and increase sustainability. The uptake of genome-editing technologies in plant breeding greatly depends on how governments regulate its use. Some major agricultural production countries have already developed regulatory approaches that enable the application of genome editing for crop improvement, while other governments are in the early stages of formulating policy. Central to the discussion is the principle of "like products should be treated in like ways" and the subsequent utilization of exclusions and exemptions from the scope of GMO regulations for these products. In some countries, the outcomes of genome editing that could also have been achieved through conventional breeding have been defined as not needing GMO regulatory oversight. In this paper, we provide a short overview of plant breeding and the history of plant biotechnology policy development, the different classes of current regulatory systems and their use of exemptions and exclusions for genome-edited plants, and the potential benefits of such approaches as it relates to achieving societal goals.
引用
收藏
页码:609 / 626
页数:18
相关论文
共 50 条
  • [1] Impacts of the regulatory environment for gene editing on delivering beneficial products
    Daniel Jenkins
    Raymond Dobert
    Ana Atanassova
    Chloe Pavely
    In Vitro Cellular & Developmental Biology - Plant, 2021, 57 : 609 - 626
  • [2] Correction to: Impacts of the regulatory environment for gene editing on delivering beneficial products
    Daniel Jenkins
    Raymond Dobert
    Ana Atanassova
    Chloe Pavely
    In Vitro Cellular & Developmental Biology - Plant, 2022, 58 : 188 - 188
  • [3] Impacts of the Regulatory Environment for Gene Editing on Delivering Beneficial Products.
    Jenkins, D.
    Pavely, Chloe
    Atanassova, A.
    Dobert, R.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2021, 57 (SUPPL 1) : S27 - S27
  • [4] Impacts of the regulatory environment for gene editing on delivering beneficial products (vol 57, pg 609, 2021)
    Jenkins, Daniel
    Dobert, Raymond
    Atanassova, Ana
    Pavely, Chloe
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT, 2022, 58 (01) : 188 - 188
  • [5] Global regulatory landscape for evaluation of products derived from gene editing
    Nesbitt, Clint
    JOURNAL OF ANIMAL SCIENCE, 2019, 97 : 57 - 57
  • [6] THE ENVIRONMENT AND REGULATORY IMPACTS
    FREEMAN, JI
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1993, 202 (07) : 1094 - 1094
  • [7] Delivering on the promise of gene editing for cystic fibrosis
    Hodges, Craig A.
    Conlon, Ronald A.
    GENES & DISEASES, 2019, 6 (02) : 97 - 108
  • [8] Regulatory aspects of gene editing in Argentina
    Alfredo Lema, Martin
    TRANSGENIC RESEARCH, 2019, 28 (Suppl 2) : 147 - 150
  • [9] Regulatory aspects of gene editing in Argentina
    Martin Alfredo Lema
    Transgenic Research, 2019, 28 : 147 - 150
  • [10] Gene Editing Regulatory and Translation to Clinic
    Ando, Dale
    Meyer, Kathleen
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (05) : 797 - +